Nov 20 2026 This Week in Cardiology
Episode Ep 431 37 min 55s

Nov 20 2026 This Week in Cardiology

The failures of ZEUS, HORIZON, and CorCal; numerous papers from the JACC special issue on LAAC; and the COAST-AF trial in JAMA are the topics John Mandrola, MD, discusses in this week’s podcast. 

This podcast is intended for healthcare professionals only. 

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I Failure of ZEUS/HORIZON at AHA and CorCal at ESC 

Three Lessons From the 'Negative' ZEUS and HORIZON Trials of IL-6- and Lp(a)-Lowering Drugs https://www.medscape.com/viewarticle/three-lessons-negative-zeus-and-horizon-trials-il-6-and-lp-2026a10015vj

  • ZEUS Trial https://www.nejm.org/doi/full/10.1056/NEJMoa2612126
  • HORIZON Trial https://www.nejm.org/doi/10.1056/NEJMoa2610159
  • TARGET-CTCA Trial https://www.nejm.org/doi/10.1056/NEJMoa2608903
  • CorCal Press Release https://www.escardio.org/news/press/press-releases/new-data-presented-on-the-use-of-coronary-artery-calcium-for-cardiovascular-risk-assessment/

II LAAC Evidence

  • ASAP-TOO Trial 10.1016/j.jacc.2026.10.007
  • Regulatory History of Watchman LAAC Device 10.1016/j.jacc.2026.08.044

III More Papers from the JACC Special Issue on LAAC 

  • Insurer Coverage of Percutaneous LAAO 10.1016/j.jacc.2026.07.038
  • LAAO in the United States, 2016-2025: Utilization, Patient Selection, and Acute Outcomes 10.1016/j.jacc.2026.09.022
  • LAAC for AF: Overhyped Device or Reasonable Alternative to OAC? 10.1016/j.jacc.2026.05.017

IV COAST-AF – A Breakthrough in AF Ablation or More Noise?

  • COAST-AF Trial https://jamanetwork.com/journals/jama/fullarticle/2856404
  • STAR AF II Trial https://www.nejm.org/doi/full/10.1056/NEJMoa1408288

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington 

Questions or feedback, please contact [email protected] 


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Community discussion